Amarantus Bioscience Holdings, Inc.
(Other OTC/NBB : AMBS)

( )
AMBS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.36%80.240.9%$594.15m
CELGCelgene Corporation
1.57%138.861.1%$558.43m
AMGNAmgen Inc.
2.36%186.191.1%$449.83m
BIIBBiogen Inc.
2.62%344.471.2%$386.48m
REGNRegeneron Pharmaceuticals, Inc.
-0.70%442.562.7%$317.95m
ALNYAlnylam Pharmaceuticals, Inc
-2.61%118.7010.7%$256.31m
VRTXVertex Pharmaceuticals Incorporated
0.23%155.051.9%$221.45m
INCYIncyte Corporation
-0.82%115.642.5%$207.97m
ALXNAlexion Pharmaceuticals, Inc.
1.65%143.161.9%$182.04m
ILMNIllumina, Inc.
0.12%206.483.5%$139.87m
EXELExelixis, Inc.
-2.48%28.306.5%$135.44m
CLVSClovis Oncology, Inc.
-3.85%81.3216.5%$124.68m
BLUEBluebird Bio, Inc.
-2.16%140.2017.3%$118.12m
SRPTSarepta Therapeutics, Inc.
1.95%51.7216.9%$110.02m
BMRNBioMarin Pharmaceutical Inc.
-1.18%93.544.4%$103.49m

Company Profile

Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.